Brief: ABL Diagnostics (ABLD) Announces The Filing Of A Takeover Bid For Integragen
11/09/2026 12:20
BRIEF-ABL Diagnostics (ABLD) Announces The Filing Of A Takeover Bid For Integragen Sept 11 (Reuters) - AbL Diagnostics SA ABLD.PA:
ABL DIAGNOSTICS (ABLD) ANNOUNCES THE FILING OF A TAKEOVER BID FOR INTEGRAGEN
ABL DIAGNOSTICS - PROPOSED ACQUISITION SUBJECT TO COMMERCIAL COURT OF ÉVRY DECISION
Source text: ID:nBw3YS2BLa
Further company coverage: ABLD.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbL Diagnostics SA
See all newsBrief: Abl Texcell Diagnostics Raises Its 2026 Revenue Guidance To €13.5 Million - €14.0 Million
Brief: ABL Texcell Diagnostics Announces Proposed Acquisition Of Vela Diagnostics In Singapore, US
Brief: ABL Diagnostics - Changes Name To ABL Texcell Diagnostics
Brief: ABL Diagnostics (ABLD) Announces The Filing Of A Takeover Bid For Integragen
Brief: ABL Diagnostics Delays Half-Yearly Accounts To 30 June 2023